John C.M. Farquhar Sells 32,676 Shares of Heartflow (NASDAQ:HTFL) Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John C.M. Farquhar sold 32,676 shares of the stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $45.00, for a total value of $1,470,420.00. Following the sale, the chief executive officer directly owned 388,044 shares in the company, valued at $17,461,980. This trade represents a 7.77% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Friday, August 14th, John C.M. Farquhar sold 15,560 shares of Heartflow stock. The shares were sold at an average price of $39.06, for a total value of $607,773.60.
• On Monday, August 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.31, for a total value of $638,730.22.
• On Friday, July 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $27.75, for a total transaction of $626,095.50.
• On Wednesday, June 24th, John C.M. Farquhar sold 38,900 shares of Heartflow stock. The shares were sold at an average price of $35.00, for a total transaction of $1,361,500.00.
• On Wednesday, June 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.50, for a total transaction of $643,017.00.

Heartflow Trading Up 6.3%

Heartflow stock opened at $49.75 on Friday. Heartflow, Inc. has a 1-year low of $20.13 and a 1-year high of $50.48. The firm has a market capitalization of $4.33 billion and a PE ratio of -27.19. The firm’s 50 day simple moving average is $30.66 and its 200 day simple moving average is $28.32.

Heartflow (NASDAQ:HTFL) last announced its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The firm had revenue of $64.08 million during the quarter. Heartflow’s revenue for the quarter was up 47.7% on a year-over-year basis. Research analysts forecast that Heartflow, Inc. will post -0.82 earnings per share for the current year.

Institutional Investors Weigh In On Heartflow

A number of large investors have recently added to or reduced their stakes in HTFL. Vanguard Group Inc. bought a new stake in Heartflow during the third quarter worth about $48,871,000. Legal & General Group Plc purchased a new position in shares of Heartflow during the 3rd quarter valued at about $59,000. Franklin Resources Inc. bought a new stake in Heartflow in the 3rd quarter worth approximately $10,829,000. UBS Group AG bought a new stake in Heartflow in the 3rd quarter worth approximately $5,130,000. Finally, Sei Investments Co. purchased a new stake in Heartflow in the third quarter worth approximately $303,000.

Analyst Upgrades and Downgrades

Several research firms have weighed in on HTFL. JPMorgan Chase & Co. raised their price target on Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a report on Friday, August 14th. Weiss Ratings raised Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, August 7th. Robert W. Baird set a $45.00 price objective on shares of Heartflow in a research report on Friday, August 14th. Wells Fargo & Company raised their target price on shares of Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a research note on Friday, August 14th. Finally, Piper Sandler reissued an “overweight” rating and issued a $45.00 price target (up from $38.00) on shares of Heartflow in a research note on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $43.43.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.